WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 2.4% of their position (5K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $2.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/16/2025ACC: 0001213900-25-122429
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+5K
Net shares
Net buyer
$2.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$0.41
Trade value
$1.02K
% of position
1.2%
12/15/2025
211.93K→214.43K
Common Stock
Direct
Shares
+2.50K
Price / share
$0.42
Trade value
$1.05K
% of position
1.2%
12/15/2025
214.43K→216.93K
Total
Net shares
+5K
Net value
$2.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | P · Purchase | +2.50K | $0.41 | $1.02K | 1.2% | 211.93K | 214.43K |
| Common Stock Direct | 12/15/2025 | P · Purchase | +2.50K | $0.42 | $1.05K | 1.2% | 214.43K | 216.93K |
| Total | +5K | $2.08K | ||||||
Derivative Transactions0
No derivative transactions reported